Step back into the energy of Advanced Therapies Week 2026.
Watch the leaders, innovators, and investors shaping the future of cell and gene therapy, captured live across the show floor, theatres, and networking lounges. Real conversations. Real insights. Real momentum.
Jump to:
Please note: not all sessions at Advanced Therapies Week 2026 were recorded. The videos below highlight a selection of sessions from across the event.
Lead through growth - Strategies for funding, talent, and tough decisions
09 Feb 2026 | 01:30 PM - 02:30 PM
From invisible to indispensable: How biotech can build a lean marketing engine
Feb 09 | 02:30 PM - 03:30 PM
Driving End-to-End Success in Cell Therapy: Automated, Modular Solutions for Autologous and Allogeneic Workflows
Feb 10 | 08:00 AM - 09:00 AM
From manual to machine: The shifting landscape of cell therapy automation
Feb 10 | 11:30 AM - 11:45 AM
Key Considerations in Preparing for Commercial Approval and Launch
Feb 10 | 12:30 PM - 01:30 PM
Integrating automation in early development
Feb 10 | 02:00 PM - 02:15 PM
Delivering scalable and affordable cell therapy
Feb 10 | 02:15 PM - 02:30 PM
Comparability by design: What worked, what broke, what’s next
Feb 10 | 04:00 PM - 04:40 PM
From days to hours: The closest you can get to real-time sterility testing for cell & gene therapies
Feb 10 | 04:45 PM - 05:00 PM
From Bottleneck to Breakthrough: QC’s Automated Evolution
Feb 10 | 08:00 AM - 09:00 AM
Designing flexible bioseparation strategies for scalable manufacturing
Feb 10 | 11:45 AM - 12:00 PM
Advancing CAR-T Cell Therapy Workflow with Novel Cell Selection and Non-Viral Delivery Methods
Feb 10 | 12:30 PM - 01:00 PM
Rapid implementation of the Accellix Automated Platform in GMP manufacturing
Feb 10 | 01:15 PM - 01:45 PM
Solving cell therapy manufacturing bottlenecks: evaluating closed and automated approaches
Feb 10 | 03:45 PM - 04:45 PM
Collaborating for success: Leveraging platforms solutions and pre-engineering to simplify
Feb 10 | 04:45 PM - 05:00 PM
Advancing CNS gene therapies with manufacturable AAV capsids and an FDA-Integrated regulatory approach
Feb 10 | 11:30 AM - 11:45 AM
Combining startup incubation and GMP manufacturing through public–private partnership
Feb 10 | 11:45 AM - 12:00 PM
Bench-to-bedside development of gene therapy products
Feb 10 | 02:30 PM - 02:45 PM
Collaborative models to accelerate cell and gene therapy translation
Feb 10 | 02:45 PM - 03:00 PM
CDMO partnerships vs in-house manufacturing in advanced therapies
Feb 10 | 02:45 PM - 03:00 PM
Inside the CDMO Landscape: Factors Shaping Advanced Therapies Manufacturing
Feb 10 | 03:30 PM - 03:45 PM
Mitigating Cryopreservation Risks with a Single-use Solutions Partner
Feb 11 | 10:00 AM - 10:15 AM
The rise of modular manufacturing: Scalable solutions to accelerate novel therapy development
Feb 11 | 10:15 AM - 10:30 AM
Vitrafy: Elevating cryopreservation from a step to a process
Feb 11 | 10:30 AM - 10:45 AM
AutoCell - Push a Button and Walk Away Cell Therapy Manufacturing
Feb 11 | 11:00 AM - 11:15 AM
Improving purification of viral vectors using Smart Polymer™ affinity ligands
Feb 11 | 11:15 AM - 11:30 AM
Functional restoration in complete SCI: A first-in-class therapy advancing to first-in-human
Feb 11 | 01:00 PM - 01:15 PM
ODC™ (Oligo Dependent Cytotoxicity): Novel class of targeted DNA/RNA therapeutics for cancer, autoimmunity & inflammation
Feb 11 | 01:15 PM - 01:30 PM
TQ Therapeutics: CELLfinity – Hybrid in vivo CGT for scalable patient access
Feb 11 | 01:30 PM - 01:45 PM
Micro Pharmacies
Feb 11 | 01:45 PM - 02:00 PM
Live-cel(tm) Therapy - a Safe and Effective Treatment for Fabry Disease
Feb 11 | 02:15 PM - 02:30 PM
Pythera Therapeutics
Feb 11 | 02:30 PM - 02:45 PM
Zelig Tx: Developing a cure for allergies
Feb 11 | 02:45 PM - 03:00 PM
Reversing Alzheimers via gene therapy and molecular glues
Feb 11 | 03:45 PM - 04:00 PM
Building Scalable Cell Therapy Workflows: Media, Process, and Automation in Action
Feb 11 | 08:00 AM - 09:00 AM
Democratizing Gene-Modified Cell Therapy Through Lipid-Based Transfection
Feb 11 | 10:30 AM - 10:45 AM
Novel, redosable in vivo CAR platform for reprogramming multiple immune cell types against solid tumors
Feb 11 | 10:45 AM - 11:00 AM
Applying 20 Years of Cell Therapy Point-of-Care Manufacturing Lessons to Automated CD19 CAR-T Production
Feb 11 | 11:00 AM - 11:15 AM
Spotlight: From bottleneck to breakthrough: Scaling viral vectors without breaking the bank
Feb 11 | 11:15 AM - 11:30 AM
Next gen tools for cell therapy manufacturing: Addressing key reagent challenges
Feb 11 | 02:00 PM - 02:15 PM
NGS-Driven quality: Redefining biosafety and release strategies in advanced therapy manufacturing
Feb 11 | 02:15 PM - 02:30 PM
The Mygotic Process -The next advancement in the production of autologous totipotent cells from somatic cells
Feb 11 | 02:45 PM - 03:00 PM
Digital Integration in Cell Therapy: Enabling Scalable MES and Accelerating Manufacturing
Feb 11 | 08:00 AM - 08:30 AM
Allogeneic therapies as a pathway to long-term scalability
Feb 11 | 02:00 PM - 02:15 PM
Standardizing material management in cell and gene therapy: A consensus framework for quality, risk, and regulatory alignment
Feb 11 | 04:00 PM - 04:15 PM
The key to accessibility and ROI: Microbubbles unlock speed, quality, and cost efficiency in CGT manufacturing
Feb 11 | 11:15 AM - 11:30 AM
Beyond the data on international day of women and girls in science
Feb 11 | 11:15 AM - 12:00 PM
SynCav1 Gene Therapy for CNS Disorders
Feb 12 | 11:00 AM - 11:15 AM
Challenges for CNS directed gene therapies for rare neurogenetic disease
Feb 12 | 11:15 AM - 11:30 AM
Curative cell therapies for type 1 diabetes: how close are we?
Feb 12 | 11:30 AM - 11:45 AM
Biomarkers and Companion diagnostics in CGT Trials: Enabling precision and predictability
Feb 12 | 11:00 AM - 11:15 AM
Exploring novel cell sources to overcome limitations in current modalities
Feb 12 | 11:45AM - 12:00 PM
Pre-register for Advanced Therapies Week 2027
Tickets aren't yet available, we'll be launching the Pre-Sale soon, so register your details below to be the first to receive the link.
